ERBB3 and Familial prostate cancer: NRG-4, HER3 and HER4 expression have been documented in a subset of prostrate cancers.[54] Prostate cancers that overexpress HER3 depend on its expression for malignant progression.[55] In prostate cancer, unlike in many other cancer types, high HRG expression is associated with favorable outcomes.